Abstract:Abstract Background Cystic fibrosis is the most common autosomal recessive genetic disease in Caucasians. It is caused by mutations in the CFTR gene, leading to poor hydration of mucus and impairment of the respiratory, digestive, and reproductive organ functions. Advancements in medical care have led to markedly increased longevity of patients with cystic fibrosis, but new complications have emerged, such as early onset of colorectal cancer. Although the pathogenesis of colorectal cancer in cystic fibrosis remains unclear, altered host-microbe interactions might play a critical role. To investigate this, we characterized changes in the microbiome and host gene expression in the colonic mucosa of cystic fibrosis patients relative to healthy controls, and identified host gene-microbiome interactions in the colon of cystic fibrosis patients. Methods We performed RNA-seq on colonic mucosa samples from cystic fibrosis patients and healthy controls to determine differentially expressed host genes. We also performed 16S rRNA sequencing to characterize the colonic mucosal microbiome and identify gut microbes that are differentially abundant between patients and healthy controls. Lastly, we modeled associations between relative abundances of specific bacterial taxa in the gut mucosa and host gene expression. Results We find that 1543 genes, including CFTR , show differential expression in the colon of cystic fibrosis patients compared to healthy controls. These genes are enriched with functions related to gastrointestinal and colorectal cancer, such as metastasis of colorectal cancer, tumor suppression, p53, and mTOR signaling pathways. In addition, patients with cystic fibrosis show decreased gut microbial diversity, decreased abundance of butyrate producing bacteria, such as Ruminococcaceae and Butyricimonas , and increased abundance of other taxa, such as Actinobacteria and Clostridium . An integrative analysis identified colorectal cancer-related genes, including LCN2 and DUOX2 , for which gene expression is correlated with the abundance of colorectal cancer-associated bacteria, such as Ruminococcaceae and Veillonella . Conclusions In addition to characterizing host gene expression and mucosal microbiome in cystic fibrosis patients, our study explored the potential role of host-microbe interactions in the etiology of colorectal cancer in cystic fibrosis. Our results provide biomarkers that may potentially serve as targets for stratifying risk of colorectal cancer in patients with cystic fibrosis.

CFTR and colorectal cancer susceptibility: an urgent need for further studies

Interactions between the gut microbiome and host gene regulation in cystic fibrosis

Cystic Fibrosis and Cancer: Unraveling the Complex Role of CFTR Gene in Cancer Susceptibility

The Clinical Biology of Cystic Fibrosis Transmembrane Regulator Protein: Its Role and Function in Extrapulmonary Disease

Germline Variants of <i>CYBA</i> and <i>TRPM4</i> Predispose to Familial Colorectal Cancer

Functional Consequences of CFTR Interactions in Cystic Fibrosis

Consistent Assignment of Risk and Benign Allele at rs2303153 in the CF Modifier Gene SCNN1B in Three Independent F508del- CFTR Homozygous Patient Populations

Structural mechanisms of CFTR function and dysfunction

Evolving data on risk and current screening recommendations for colorectal cancer in cystic fibrosis: Pre- and posttransplant

Genome-Wide Association and Transcriptome-Wide Association Studies Identify Novel Susceptibility Genes Contributing to Colorectal Cancer

Low-Penetrance Susceptibility Variants in Colorectal Cancer-Current Outlook in the Field

Intestinal Inflammation and Alterations in the Gut Microbiota in Cystic Fibrosis: A Review of the Current Evidence, Pathophysiology and Future Directions

An update on the genetics of colorectal cancer

S2599 A Rare Cystic Fibrosis Gene Mutation Associated With GI Manifestations in the Absence of Pulmonary Disease

CFTR and cystic fibrosis

Cftr deletion in mouse epithelial and immune cells differentially influence the intestinal microbiota

Bacterial translocation and barrier dysfunction enhance colonic tumorigenesis

Cross-talk between CFTR and sphingolipids in cystic fibrosis

CFTR function, pathology and pharmacology at single-molecule resolution

A bibliometric analysis of cystic fibrosis transmembrane conductance regulators

Disrupted Interaction Between CFTR and AF-6/afadin Aggravates Malignant Phenotypes of Colon Cancer.